Quantitative analysis of apoptosis and bcl-2 in Sjogren's syndrome

Journal of Rheumatology

Volumn 24, Issue 8, 1997, Pages 1552-1557

  Manganelli, Paolo ^a,c   Quaini, Federico ^b   Andreoli, Anna M ^b   Lagrasta, Costanza ^b   Pilato, Francesco P ^b   Zuccarelli, Alessandra ^b   Monteverdi, Riccardo ^a   D'Aversa, Claudia ^b   Olivetti, Giorgio ^b  

^a Parma Hospital   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

apoptosis; bcl 2; epithelial damage; Sjogren's syndrome

Indexed keywords

PROTO ONCOGENE BCL 2; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SALIVARY GLAND; SJOEGREN SYNDROME;

AGED; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; DNA DAMAGE; DOWN-REGULATION; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 0030812172     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Moutsopoulos HM, Chused TM, Mann DL, et al: Sjögren's syndrome (sicca syndrome): Current issues. Ann Intern Med 1980;92:212-6.
2. Fox RI, Kang HI: Pathogenesis of Sjögren's syndrome. Rheum Dis Clin North Am 1992;18:517-38.
3. Griffiths GM, Mucller C: Expression of perforin and granzymes in vivo: Potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991;12:415-9.
4. Tsubota K, Saito I, Miyasaka N: Granzyme A and perform expressed in the lacrimal glands of patients with Sjögren's syndrome. Am J Ophthalmol 1994;117:120-1.
5. Alpert S, Kang H-I, Weissman I, Fox RI: Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. Arthritis Rheum 1994;37:1046-54.
6. Nagata S, Golstein P: The Fas death factor. Science 1995;267:1449-56.
7. Ueda N, Shah SV: Apoptosis. J Lab Clin Med 1994;124:169-77.
8. Schwartzman RA, Cidlowski JA: Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 1993;14:133-51.
9. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 1992;80:879-86.
10. Vitali C, Bombardieri S, Moutsopoulos HM, et al: Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
11. Kajstura J, Cheng W, Reiss K, et al: Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
12. Quaini F, Cigola E, Sala R, et al: Apoptosis in the infarcted human heart. Basic Appl Myology 1996;6:240-50.
13. Olivetti G, Quaini F, Sala R, et al: Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-16.
14. Hsu SM, Raine I, Fanger H: Use of avidin-biotin-peroxidase complex in immunoperoxidase techniques. J Histochem Cytochem 1981;29:577-80.
15. Skopouli FN, Fox PC, Galanopoulou V, Atkinson JC, Jaffe ES, Moutsopoulos HM: T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. J Rheumatol 1991;18:210-4.
16. Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142:67-77.
17. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ by specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
18. Kong L, Dang H, Ogawa N, et al: Elevated Fas expression and blocked apoptosis on infiltrating lymphocytes from salivary glands from patients with primary Sjögren's syndrome (abstr). Arthritis Rheum 1995;(suppl)38:S378.
19. Manganelli P, Salaffi F, Nervetti A, Raffaini N, Olivetti G: Morphometric study of salivary glands in primary Sjögren's syndrome. Clin Exp Rheumatol 1989;7:273-6.
20. Moutsopoulos HM: Sjögren's syndrome: Autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-5.
21. Durdick I, Byard RW, Carnegie JA: A review of the proliferative capacity of major salivary glands and the relationship to current concepts of neoplasia in salivary glands. Oral Surg Oral Med Oral Pathol 1990;69:53-67.
22. Lu Q-L, Abel P, Foster CS, Lalani E-N: Bcl-2: Role in epithelial differentiation and oncogenesis. Hum Pathol 1996;27:102-10.
23. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 1993;75:229-40.
24. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
25. Boise LH, Gonzalez-Garcia M, Postema CE, et al: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
26. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for bcl-xl and bcl-2, displaces bax and promotes cell death. Cell 1995;80:285-91.
27. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 1991;351:453-6.
28. Takayama S, Sato T, Krajeski S, et al: Cloning and functional analysis of BAG-1: A novel bcl-2 binding protein with anti-cell death activity. Cell 1995;80:279-84.
29. Krajewsky S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC: Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994;145:515-25.
30. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-7.
31. Matsumura E, Kagami M, Tomioka H, et al: Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome. Clin Exp Rheumatol 1996;14:309-11.
32. Matsumoto I, Namekawa T, Hasunuma T, Maeda T, Nishioka K, Sumida T: Fas-sensitive T cell receptor in labial salivary glands from patients with Sjögren's syndrome (abstr). Arthritis Rheum 1996;(suppl)39:S288.
33. Saito K, Amano K, Koide J, Takeuchi T, Abe T: Expression of cytotoxic granules in CD4+ T cells in Sjögren's syndrome (abstr). Arthritis Rheum 1996;(suppl)39:S288.